opment of type 2 diabetes and cardiovascular disease [3] . The incidence of NAFLD is rapidly increasing worldwide because of the obesity and type 2 diabetes epidemics [4, 5] . The prevailing hypothesis for the pathogenesis of NAFLD is inflammation and fibrosis caused by chronic fatty infiltration in the liver [6] . NAFLD is considered the leading cause of cryptogenic cirrhosis [7] .
Vitamin D is a multifactorial hormone that affects aspects of metabolism in the human body from immune function to bone metabolism [8] . Vitamin D insufficiency and deficiency are considered serious public health problems [9] . Recent studies demonstrate that Vitamin D deficiency may predispose an individual to metabolic bone diseases and to cancer, insulin resistance, metabolic syndrome, type 2 diabetes and cardiovascular diseases [10] [11] [12] [13] [14] .
the Health Promotion Center at Kangbuk Samsung Hospital, Sungkyunkwan University, Seoul, Korea. The purpose of the medical health checkup program is to promote the health of employees through regular health checkups and to enhance early detection of existing diseases. Most of the examinees are the employees of various industrial companies from all over the country and their family members. The costs of the medical examinations are largely paid for by their employers, and a considerable proportion of the examinees undergo examinations annually or biannually.
Various exclusion criteria were applied to the 67,183 men who participated in the medical checkup program in 2010. We excluded subjects without abdominal ultrasonogram data (n = 194), without serum 25(OH) D 3 levels (n = 26,333), positive for serologic markers of hepatitis B or C virus (n = 1,742), with illnesses that could affect liver function including viral and autoimmune hepatitis, liver cirrhosis, malignancy and diabetes mellitus (n = 4,398), who drank alcohol in excess of 20 g/day (n = 20,676), with stones or polyps in gall bladder (n = 1,475), with serum 25(OH)D 3 levels more than two standard deviations from the population mean (5, 160) and subjects with any missing data for necessary parameters or on the questionnaire (n = 440). These vigorous exclusion criteria resulted in a final study population of 6,567 subjects ( Fig. 1) .
Informed consent for the use of the health screening data for the research was obtained from the participants. The design and the protocol of this study was reviewed and approved by the Institutional Review Board of Kangbuk Samsung Hospital and is in accordance with the Helsinki Declaration of 1975.
Anthropometric and laboratory measurements
Height and weight were measured twice and then averaged. The body mass index (BMI) was calculated by dividing the weight (kg) by the square of the height (m). Waist circumference was measured at the level of the umbilicus by a single examiner with the subject in the standing position. Blood pressure was measured using a standardized sphygmomanometer after five minutes of rest. A smoker was defined as a subject who had smoked at least five total packs of cigarettes in his lifetime. Exercise status was assessed by the self-reported questionnaire and marked yes if the participant undertook regular exercise of moderate intensity for more than 20 minutes at least three times a week for at least 1 month before the examination. As
The mechanism of the association of vitamin D and NAFLD is believed to be related to oxidative stress and inflammation. These two diseases share inflammation as the common pathogenic mechanism. The vitamin D receptor is constitutively expressed by macrophages, and in lipopolysaccharide-stimulated murine macrophages, 1,25(OH) 2 D 3 upregulates the inhibitor of nuclear factor (NF)-κB (IκB-α) by increasing mRNA stability and decreasing IκB-α phosphorylation, suggesting that 1,25(OH)2D 3 has an anti-inflammatory action in macrophages [15, 16] .
Because inflammation and oxidative stress might act as the common pathogenic mechanisms of NAFLD and vitamin D deficiency, and as both diseases are associated with insulin resistance, type 2 diabetes and cardiovascular disease, studies have been recently performed to examine the relationship of vitamin D levels with the development of NAFLD [17] [18] [19] [20] [21] [22] . Previous studies showed that low vitamin D levels were associated with the development of NAFLD, although the numbers of subjects included in the studies were small [17, 18, 22] . In contrast, a recent report by Katz et al. that included 1,630 young adolescents did not find that vitamin D status was associated with suspected NAFLD (defined as elevated alanine transferase (ALT) levels only) after adjustment for obesity and metabolic syndrome [21] . Thus, although several studies have been performed to examine the association between vitamin D levels and NAFLD, no conclusion could be reached because of small sample size, differences in the definition of NAFLD, and conflicting results.
As NAFLD and metabolic syndrome are considered to stem from the same pathogenic paradigm, the association of vitamin D deficiency with NAFLD may be related to its possible link with abdominal obesity and metabolic syndrome. Therefore, we analyzed the association of vitamin D levels with NAFLD after adjusting for confounding metabolic parameters and metabolic syndrome to determine if their association is independent of obesity and metabolic syndrome. Our study population included 6,567 apparently healthy Korean men who underwent abdominal ultrasonography and who had serum vitamin D levels within the normal range.
Patients and Methods

Study population
In this cross-sectional study, the subjects were male participants in a medical health checkup program at National Glycohemoglobin Standardization Program (NGSP) [23] . The intra-assay coefficient of variation (CV) was 2.3% and interassay CV was 2.4%, both within the NGSP acceptable limits [24] .
The presence of diabetes mellitus was determined based on the self-reported questionnaire completed by the participants and the diagnostic criteria of American Diabetes Association [25] . Insulin resistance was measured using the homeostatic model of the assessment of insulin resistance (HOMA-IR) and was obtained by applying the following formula: HOMA-IR = fasting insulin (IU/mL) × fasting blood glucose (mmol/ L)/22.5 [26] . The presence or absence of metabolic syndrome was defined according to the criteria of the International Diabetes Federation and the American Heart Association/National Heart, Lung, and Blood Institute [27] .
To assess vitamin D status, serum 25-hydroxyvitamin D 3 (OH)D 3 was measured with an electrochemiluminescence immunoassay using the Elecsys 25-OH-D 3 vitamin assay on Modular E170 immunoanalyzer (Roche, Mannheim, Germany).
Assessment of presence or absence of NAFLD
The diagnosis of NAFLD was based on abdominal ultrasonography results with a 3.5-MHz transducer (Logic Q700 MR; GE, Milwaukee, WI, USA). Three experienced radiologists who were blinded to both the study aims and laboratory values performed the ultrasonography. Images were captured in a standard fashion with the patient in the supine position with their serum vitamin D levels have seasonal variation due to the skin exposure to sun, the month of health checkup was included as a categorical variable.
All of the subjects were examined after an overnight fast. Serum calcium level was measured by the O-cresolphthalein complexone method (Hitachi Modular D2400; Roche, Tokyo, Japan). Serum aspartate aminotransferase (AST) and ALT levels were measured by photometric UV test (Hitachi Modular D2400; Roche, Tokyo, Japan). The hexokinase method was used to assess fasting glucose concentrations (Hitachi Modular D2400; Roche, Tokyo, Japan). Hepatitis B surface antigen, antibody to Hepatitis B surface antigen and antibody to hepatitis C virus were measured by an electrochemiluminescence immunoassay (Hitachi Modular E170; Roche, Tokyo, Japan). Fasting insulin concentrations were determined by an electrochemiluminescence immunoassay (Hitachi Modular E170; Roche, Tokyo, Japan). An enzymatic calorimetric test was used to measure the total cholesterol (TC) and triglyceride concentrations. The selective inhibition method was used to measure the level of high-density lipoprotein cholesterol (HDL-C), and a homogeneous enzymatic calorimetric test was used to measure the level of low-density lipoprotein cholesterol (LDL-C).
Glycated hemoglobin (HbA1c) was measured with an immunoturbidimetric assay using a Cobra Integra 800 automatic analyzer (Roche Diagnostics, Basel, Switzerland) with a reference value of 4.4 -6.4%. The methodology was aligned with the standards of the Diabetes Control and Complications Trial (DCCT) and right arm raised above their head. All ultrasonographic images were stored on the image server and were also recorded with instant film for later inspection by the radiologists and physicians. Of the four known criteria for fatty liver disease (hepatorenal echo contrast, liver brightness, deep attenuation and vascular blurring), a diagnosis of NAFLD in our study required the participant to show hepatorenal echo contrast and liver brightness [28, 29] .
Statistical analysis
All data are presented as the mean and standard deviation (SD), and were analyzed using SPSS Windows version 18.0 (SPSS Inc., Chicago, IL, USA 
Results
Patient characteristics
The mean age of the participants was 42 years (range 24 -75 years). The mean BMI of the subjects was 24.7 ± 2.8 kg/m 2 (range 16.17-39.64 kg/m 2 ) and 2,863 subjects (43.6%) had NAFLD ( Table 1 ). The mean serum 25(OH)D 3 level was 39.4 ± 9.2 nmol/L. The mean 25(OH)D 3 level significantly increased with increasing participants' age (Fig. 2) . Metabolic syndrome was diagnosed in 1,385 participants (21.1%). 
Comparisons of various parameters in the presence or absence of NAFLD
To analyze the effect of presence of NAFLD on various parameters, mean values of the variables were compared in participants with and without NAFLD ( Table 3) . sis with NAFLD as the dependent variable, the participants with the highest tertile of 25(OH)D 3 levels had a significantly lower risk of NAFLD compared with those in the lowest tertile. The significantly increased risk of NAFLD in participants with lower vitamin D levels remained significant even after adjustment for the presence of metabolic syndrome, suggesting that the role of vitamin D in NAFLD development is independent of metabolic syndrome. As far as we know, this is the first cross-sectional study to analyze the relationship between serum vitamin D levels and NAFLD in a sufficiently large number of participants.
Vitamin D can be obtained from exogenous sources or can be endogenously synthesized from cholesterol [30] . Endogenous synthesis is initiated in the skin by the conversion of 7-dehydrocholesterol to previtamin D3 by ultraviolet radiation [31] . Through two sequential hydroxylation steps in the liver and then in the kidney, the active form of vitamin D, 1,25(OH) 2 D, is formed. The bioavailability of vitamin D is disturbed by obesity, and we can hypothesize that low body concentration or low bioavailability of vitamin D may be strongly associated with increased fatness and vice versa [32] . It has also been postulated that vitamin D might increase peripheral insulin action by stimulating the expression of insulin receptors and that it is associated with insulin secretion from the pancreas [33, 34] . From this information, we could predict that in humans, low vitamin D levels would have deleterious effects on insulin sensitivity and metabolic function.
There are very few studies assessing the association of vitamin D levels with the development of Participants with NAFLD were older, more obese and had worse metabolic parameters than those without NAFLD. The mean 25(OH)D 3 level was significantly lower in participants with NAFLD than in those without (39.7 ± 9.7 vs. 38.7 ± 9.0 nmol/L, p < 0.001). This difference was significant even after adjustment for BMI and the variables shown to be associated with 25(OH) D 3 level in bivariate correlation analysis, such as age, serum calcium, AST, TC and fasting insulin level.
When the proportion of subjects with NAFLD in each of the tertiles defined by 25(OH)D 3 level were compared, the proportion of participants with NAFLD significantly increased with decreasing 25(OH)D 3 levels from the first to third tertiles with the highest tertile being as the first tertile (40.0, 45.0 and 45.9%, p for linear trend < 0.001) (Fig. 3) .
Multiple logistic regression analyses with NAFLD as the dependent variable
To analyze the relationship of individual parameters with NAFLD, multiple logistic regression analyses were performed with NAFLD as the dependent variable (Table 4) . Included variables were age, calcium, HOMA-IR, ALT, total cholesterol, HDL-C, systolic BP, HbA1c, month of measurement of 25(OH)D 3 , smoking, exercise, and tertiles of BMI and 25(OH)D 3 level.
Older age, high HOMA-IR, ALT, total cholesterol and low HDL-C were the significant determinants for NAFLD (Model 1, Table 4 ). Increased BMI in the overweight (23-25 kg/m 2 ) and obese (≥ 25 kg/m 2 ) range showed an increased risk for NAFLD compared with the normal BMI group (OR 2.019 and 3.974, p < 0.001). The two lower tertiles of 25(OH)D 3 showed a significantly increased risk for NAFLD compared with the first (highest) tertile (OR 1.254 and 1.409, p < 0.05). These differences remained significant even after including the presence of metabolic syndrome in the model (Model 2, OR 1.247 and 1.408, p < 0.05).
Discussion
In this study of apparently healthy Korean men with 25(OH)D 3 levels within two standard deviations of the population mean, serum 25(OH)D 3 levels were significantly lower in participants with NAFLD detected by abdominal ultrasonogram compared with those without NAFLD. In addition, the proportion of participants with NAFLD increased as the 25(OH)D 3 level decreased. In multivariate logistic regression analy- The mechanisms underlying the role of vitamin D status in the development and progression of NAFLD have not been clearly described. In an animal study performed in Sprague Dawley rats fed a westernized diet alone or with vitamin D depletion, the vitamindeficient group showed significantly greater hepatic steatosis and lobular inflammation than the control groups [21] . Hepatic messenger mRNA levels for tolllike receptor (TLR)2, TLR4, TLR9 and other proinflammatory and oxidative stress markers were higher in the vitamin D-deficient group. This study suggests that vitamin D deficiency exacerbates NAFLD through TLR activation accompanied by increased inflammation and oxidative stress. In addition, in rat models of diet-induced and obesity-related nonalcoholic steatohepatitis (NASH), phototherapy significantly attenuated the progression of NASH but failed to ameliorate obesity and steatosis, suggesting that phototherapy may have an anti-inflammatory/antifibrotic activity rather than antiobesity/antisteatotic activity [19] . From these results, the mechanism underlying the association between vitamin D status and NAFLD could be hypothesized to involve the anti-inflammatory effects of vitamin D. More studies are needed to clarify the mechanism underlying the relationship between vitamin D level and NAFLD development.
In this study, 25(OH)D 3 levels were positively correlated with age in the bivariate correlation analysis and in the mean values of 10-year age-stratified groups. Historically, old age has been known to be a risk factor for vitamin D insufficiency because of the decline in the synthesis of vitamin D 3 with aging [35] . In a study that reviewed the published literature from six regions around the world, older age was shown to be the main factor associated with lower 25(OH)D levels [36] . However, in a previously published study of 6,925 Koreans, serum 25(OH)D levels increased with age with the peak prevalence for vitamin D insufficiency in the age range 20-29 [37] . The authors commented that this discrepancy might be because young adults tend to have indoor jobs while elderly adults tend to have outdoor jobs, and that this phenomenon is also seen in other industrialized countries. Therefore, the positive correlation between age and serum vitamin D levels observed in our study has to be interpreted in the context of the cultural and social background of the study population.
Our study has limitations. First, it included only men. Sex differences in vitamin D levels have been shown in NAFLD. In a study by Targher et al. [17] of 60 participants with biopsy-proven NAFLD and 60 healthy controls, 25(OH)D concentrations were markedly lower in NAFLD patients than in controls. Another study performed with a small number (162) of participants with NAFLD also reported an association of low 25(OH) D levels with the presence of NAFLD, independent of metabolic syndrome, diabetes or insulin resistance [22] . In contrast, a very recent study conducted using the National Health and Nutrition Examination Survey database of 1,630 American adolescents found that, after adjustment for obesity, vitamin D levels were not associated with suspected NAFLD assessed only by elevated ALT levels [20] . The authors commented that their study population was larger than those in previous studies, and that adult results might not be applicable in the adolescent population, as adults may have other confounding factors that cannot be considered in these kinds of analyses. However, our study group was larger than theirs and we assessed NAFLD status by ultrasonography. Our study results present stronger evidence that low vitamin D levels deleteriously affect NAFLD status, supporting the results of the previous smaller studies performed in adults.
In our study, the association of low vitamin D levels with NAFLD was significant even after adjustment for obesity as assessed by BMI, and for the presence of metabolic syndrome. This is in line with previously published studies that found that vitamin D might affect NAFLD status independent of obesity or metabolic syndrome [17, 22] . In the study by Gagnon et al. [13] , 25(OH)D concentrations were measured in 11,247 Australian adults at baseline and the incidence of metabolic syndrome was assessed after 5 years in the participants with complete data. The risk of metabolic syndrome was significantly higher in participants with low 25(OH)D levels than in those with high 25(OH)D levels at baseline. In that study, a significant association of 25(OH)D level with metabolic syndrome risk was present only in people with BMI of 25 kg/m 2 or higher and was lost after adjustment for baseline HOMA-IR, suggesting that insulin resistance might be the main link in the relationship between metabolic syndrome and vitamin D levels. However, in our study and others, low vitamin D levels were significantly associated with NAFLD independent of metabolic syndrome and insulin resistance. The association of NAFLD and vitamin D level might have another pathogenic mechanism that cannot be explained by obesity and insulin resistance. relationship of vitamin D concentration and NAFLD cannot be completely confirmed based on the results of this study.
In summary, we have shown that serum 25(OH)D 3 levels were significantly lower in men with NAFLD than in those without NAFLD in this sample of healthy Korean men. High vitamin D levels conferred a significantly lower risk of developing NAFLD than low vitamin D levels. This association remained significant even after adjusting for the metabolic parameters BMI and metabolic syndrome. The recognition and diagnosis of insufficient serum vitamin D in the general population is desirable to slow the rapidly increasing prevalence of NAFLD. Further prospective studies are needed to clarify the exact mechanism and relationships between vitamin D level and NAFLD. many studies [12, 38] . Menopausal status and estrogen level affect the results of analyses in women. We chose to analyze only men because of their increased proclivity for NAFLD development. In addition, there was a much smaller proportion of potential female subjects, so their inclusion could have biased the results. Second, the presence or absence of NAFLD was assessed by ultrasonogram but not by liver biopsy. However, it is inappropriate to perform liver biopsies in a large-scale epidemiologic study as it is too invasive [39] . Third, we could not exclude that some subjects were taking vitamin D supplements, as the questionnaire included only a question about taking "any vitamin", not "vitamin D". This could have biased the results. However, the proportion of men who take vitamin D supplements may be relatively lower than for women. Lastly, as this was a cross-sectional study, the cause-and-effect
